Zh Nevrol Psikhiatr Im S S Korsakova
June 2022
Objective: To evaluate the efficacy of the energotropic drug idebenon in hereditary neuromuscular pathology.
Material And Methods: A total of 9 patients with hereditary myopathies were examined during treatment with idebenone. Determination of muscle strength was carried out on the British medical research Council scale (0 points - no active movements, 5 points - no muscle weakness).
Aim: To determine the mitochondrial dysfunction in multiple sclerosis (MS).
Material And Methods: Fourteen adult patients with MS and 23 healthy people were examined. Cytochemical analysis of lymphocytes in peripheral blood was carried out.